Aurobindo Pharma Ltd.’s first-quarter profit rose, in-line with analysts’ estimates.The Hyderabad-based bulk and generic drug maker’s net profit rose 10% year-on-year to Rs 571 crore in the quarter ended June, according to an exchange filing. That compares with the Rs 557-crore consensus estimate of analysts tracked by Bloomberg.Sequentially, it rose 13%.
IMD Climate Information:The India Meteorological Division (IMD) has sounded an alert for extreme thunderstorms accompanied by cloud-to-ground lightning and hailstorm...
Israel's Ministry of Protection is in superior talks with the US administration to obtain Joint Air-to-Floor Standoff Missiles (JASSM)...
US President Donald Trump insisted he doesn’t plan to fireside Federal Reserve Chair Jerome Powell regardless of his sustained criticism...
Vedanta goals to cut back debt, put money into development capex, and concentrate on home market, insulating from international dangers....
Britain's counter-terrorism police arrested 5 males, together with 4 Iranian nationals, on suspicion of terrorism offences over a plot to...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
